www.fdanews.com/articles/134396-antiviral-pharma-chimerix-gets-81-million-contract-for-smallpox-countermeasure

Antiviral Pharma Chimerix Gets $81 Million Contract for Smallpox Countermeasure

February 17, 2011

Antiviral therapeutics company Chimerix has received a federal contract that could reach $81 million in value if the company successfully develops a medical countermeasure to a smallpox bioterrorism agent.
MedCity News